24小时热门版块排行榜

南方科技大学公共卫生及应急管理学院2025级博士研究生招生报考通知

返回列表

当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖

yang2sdu

木虫 (正式写手)

应助: 0 (幼儿园)
金币: 6298.1
散金: 38
红花: 1
帖子: 430
在线: 273.2小时
虫号: 880993
注册: 2009-10-22
专业: 药物学其他科学问题

[求助] 哪位虫友能找到美国药典USP32版附录207页的资料

哪位虫友能找到美国药典USP32版附录207页的资料？谢谢大家！

回复此楼

» 猜你喜欢

请问有评职称，把科研教学业绩算分排序的高校吗已经有3人回复
孩子确诊有中度注意力缺陷已经有12人回复
2025冷门绝学什么时候出结果已经有3人回复
天津工业大学郑柳春团队欢迎化学化工、高分子化学或有机合成方向的博士生和硕士生加入已经有4人回复
康复大学泰山学者周祺惠团队招收博士研究生已经有6人回复
AI论文写作工具：是科研加速器还是学术作弊器？已经有3人回复
2026博士申请-功能高分子，水凝胶方向已经有6人回复
论文投稿，期刊推荐已经有4人回复
硕士和导师闹得不愉快已经有13人回复
请问2026国家基金面上项目会启动申2停1吗已经有5人回复

» 本主题相关价值贴推荐，对您同样有帮助:

mannich反应为何不能反应完全已经有11人回复
编辑意见回复已经有6人回复
关于Automatica审稿意见已经有24人回复
维恩公式推导已经有3人回复
独坐夕阳下，笑看风云起，已经有39人回复
酯基在生物体内的降解过程已经有3人回复
分享三篇纳米氧化铁合成及应用的最新文献（新增EES综述一篇）已经有383人回复
农学女生考博好不好及方向已经有5人回复
中科院化学所的进来交流下已经有46人回复
中国化学会第28 届学术年会您参加了吗？（欢迎做过报告或听了报告的分享盛况！）已经有44人回复
烯炔重排已经有5人回复
博导回的邮件，求大家分析分析已经有24人回复
博导的回复，求分析！！！已经有14人回复
翻译摘要已经有4人回复
豁达人生12句金言已经有9人回复
【求助】【高分悬赏】美国药典欧洲药典日本药局方的附录目录页已经有3人回复

1楼2012-04-24 18:01:42

已阅回复此楼关注TA 给TA发消息送TA红花 TA的回帖

泡泡-211

至尊木虫 (知名作家)

PhEPI: 1
应助: 101 (高中生)
金币: 12710.8
红花: 8
沙发: 35
帖子: 7496
在线: 1516小时
虫号: 293006
注册: 2006-11-04
性别: GG
专业: 药剂学

【答案】应助回帖

★ ★
感谢参与，应助指数 +1
yang2sdu: 金币+2, ★有帮助 2012-04-25 08:20:13

现在只有USP35-NF30的，不过内容貌似一样
207 TEST FOR 1,6-ANHYDRO DERIVATIVE FOR ENOXAPARIN SODIUM
The following procedure is used to determine the levels of 1, 6-anhydro forms in enoxaparin sodium. [Note— The test for the 1,6-anhydro derivative is conducted only where specified in the individual monograph. ]

INTRODUCTION
The disaccharides specified in this general chapter are listed by name and structure in Appendix 1; the oligosaccharides are listed in Appendix 2.
Depolymerization of heparin into enoxaparin sodium produces a partial but characteristic conversion of glucosamines at the reducing termini of oligosaccharide chains with terminal glucosamine 6-O sulfate, yielding 1,6-anhydro derivatives (see Figure 1).

Figure 1. Structure of enoxaparin sodium containing a 1,6-anhydro derivative on the reducing end of the chain.
The percentage of oligosaccharide chains that are cyclized in a 1,6-anhydro ring is a characteristic of enoxaparin sodium.

DEPOLYMERIZATION OF ENOXAPARIN SODIUM BY HEPARINASES AND RESULTING OLIGOSACCHARIDES
The assay involves HPLC analysis of a depolymerized enoxaparin sodium solution by a mixture of heparinases. After enzymatic depolymerization, the main 1,6-anhydro residues of enoxaparin sodium observed are 1,6-anhydro DIIS and 1,6-anhydro D IISepi , and 1,6-anhydro DIS and 1,6-anhydro DIS– ISepi (see Appendix 2.).
The 1,6-anhydro DIS– ISepi tetrasaccharide (2-O-sulfated mannosamine form) is not completely cleaved by the heparinases. The two disaccharides (1,6-anhydro DIIS and 1,6-anhydro D IISepi ), which generally co-elute, are poorly resolved with respect to DIIA (see Appendix 1), especially because the latter occurs as two anomers:  and . To allow quantitation of 1,6-anhydro DIIS and 1,6-anhydro D IISepi , the enoxaparin sodium sample already depolymerized by heparinases is then reduced by sodium borohydride (see Figure 2).

Figure 2. Reduction of oligosaccharides by sodium borohydride
The sodium borohydride reduction eliminates the  anomeric effect by opening the terminal oligosaccharide ring. The four 1,6-anhydro derivatives (see Appendix 2.) are not reduced by sodium borohydride because the ring opening is blocked by the 1,6-anhydro bridge. The reduction of the oligosaccharides decreases their retention time, whereas the retention time of the 1,6-anhydro derivatives remains unchanged. Thus, it is possible to separate the two compounds—1,6-anhydro DIIS and 1,6-anhydro D IISepi —from the reduced DIIA disaccharide peak. [Note— 1,6-Anhydro DIIS and 1,6-anhydro D IISepi are eluted as two nonresolved peaks and are quantitated together as a single compound, 1,6-anhydro DIIS. Therefore, for the purpose of simplification, the epimeric form is not referred to in the remaining text. ]

PROCEDURE
USP Reference Standards 11 — USP Enoxaparin Sodium RS.
Solutions—
Solution A— Dissolve 0.280 g of monobasic sodium phosphate in 950 mL of water, adjust with phosphoric acid to a pH of 3.0, and dilute with water to 1000 mL.
Solution B— Dissolve 140 g of sodium perchlorate in 950 mL of Solution A, adjust with phosphoric acid to a pH of 3.0, and dilute with Solution A to 1000 mL.
Mobile Phase— Use variable mixtures of filtered and degassed Solution A and Solution B as directed in Chromatographic System.
Sodium/Calcium Acetate pH 7.0 Solution— Dissolve 10 mg of bovine serum albumin and 32 mg of calcium acetate in 60 mL of water. Add 580 μL of glacial acetic acid, and adjust with 2 M sodium hydroxide to a pH of 7.0. Transfer to a 100-mL volumetric flask, and dilute with water to volume. Pass the solution through a filter having a porosity of 0.45 or 0.22 μm.
Potassium Phosphate pH 7.0 Buffer— Dissolve 68 mg of monobasic potassium phosphate and 10 mg of bovine serum albumin in 30 mL of water in a 50-mL volumetric flask. Adjust with potassium hydroxide, if necessary, to a pH of 7.0, and dilute with water to volume. Pass the solution through a filter having a porosity of 0.45 or 0.22 μm.
Sodium Borohydride Solution— Dissolve 12 mg of sodium borohydride in 400 μL of water, and mix on a vortex mixer. [Note— Prepare fresh immediately before use. ]
Heparinase 1 Solution— Dissolve heparinase 1 (see Reagent Specifications under Reagents, Indicators, and Solutions) [reference: heparin lyase I, EC 4.2.2.7] in Potassium Phosphate pH 7.0 Buffer to obtain a solution having an activity of 0.4 IU per mL. Store the solution at –20 until ready to use. [Note— Heparinase solutions can be stored for 3 months at 20. ]
Heparinase 2 Solution— Dissolve heparinase 2 (see Reagent Specifications under Reagents, Indicators, and Solutions [no EC number] in Potassium Phosphate pH 7.0 Buffer to obtain a solution having an activity of 0.4 IU per mL. Store the solution at –20 until ready to use.
Heparinase 3 Solution— Dissolve heparinase 3 (see Reagent Specifications under Reagents, Indicators, and Solutions [reference: heparitinase I, EC 4.2.2.8] in Potassium Phosphate pH 7.0 Buffer to obtain a solution having an activity of 0.4 IU per mL. Store the solution at –20 until ready to use.
Heparinases 1, 2, 3, Solution— Prepare a 1:1:1 (v:v:v) mixture of Heparinase 1 Solution, Heparinase 2 Solution, and Heparinase 3 Solution.
Peak Identification Solutions— [Note— The depolymerized test solutions and Standard solutions must be prepared at the same time. Depolymerized test solutions are stable for 1 month at 20. Also, the reduced test solutions and Standard solutions must be prepared at the same time. Reduced solutions are also stable for 1 month at 20. ]
Disaccharide Solutions— Separately prepare a 0.25 mg per mL solution of each disaccharide1 DIA, DIIA, DIIIA, DIVA, DIS, DIIS, DIIIS, DIVS (see Appendix 1). Chromatograph each disaccharide solution, and record the peak responses.
Reduced Disaccharide Solutions— To 60 μL of each Disaccharide Solution, add 10 μL of freshly prepared Sodium Borohydride Solution. Mix on a vortex mixer, and allow to stand at room temperature for at least 4 hours. Chromatograph each solution, and record the peak response.
Blank Solution— Prepare a mixture of 20 μL of water, 70 μL of Sodium/Calcium Acetate pH 7.0 Solution, and 100 μL of the Heparinases 1, 2, 3 Solution. Mix gently by inversion, and allow to stand for at least 48 hours in a 25 water bath. Prepare a mixture of 60 μL of this depolymerized solution with 10 μL of freshly prepared Sodium Borohydride Solution. Homogenize, and allow to stand at room temperature for at least 4 hours. Chromatograph the resulting solution, and record the peak responses.
Test Solution 1— Prepare two solutions, each containing 20 mg of enoxaparin sodium in 1 mL of water.
Standard Solution 1— Prepare one solution containing 20 mg of USP Enoxaparin Sodium RS in 1 mL of water.
Test Solution 2— For each solution, prepare a mixture of 20 μL of Test Solution 1, 70 μL of Sodium/Calcium Acetate pH 7 Solution, and 100 μL of Heparinases 1, 2, 3 Solution. Mix gently by inversion, and allow to stand for at least 48 hours in a 25 water bath. After 48 hours of depolymerization, chromatograph the solution, and record the peak responses.
Standard Solution 2— Prepare a mixture of 20 μL of Standard Solution 1, 70 μL of Sodium/Calcium Acetate pH 7 Solution, and 100 μL of Heparinases 1, 2, 3 Solution. Mix gently, and allow to stand for at least 48 hours in a 25 water bath. After 48 hours of depolymerization, chromatograph the solution, and record the peak responses.
Test Solution 3— For each depolymerized test solution, prepare a mixture of 60 μL of Test Solution 2 and 10 μL of freshly prepared Sodium Borohydride Solution. Homogenize, and allow to stand loosely capped at room temperature for at least 4 hours before injecting into the chromatograph. Test Solution 3 is stable for 48 hours at room temperature.
Standard Solution 3— Prepare a mixture of 60 μL of Standard Solution 2 and 10 μL of freshly prepared Sodium Borohydride Solution. Homogenize and mix on a vortex mixer, and allow to stand loosely capped at room temperature for at least 4 hours before injecting into the chromatograph. Standard Solution 3 is stable for 48 hours at room temperature.
Chromatographic System (see Chromatography 621 )— The liquid chromatograph is equipped with a 234-nm detector and a 3-mm × 25-cm column that contains 5-μm packing L14. A guard column packed with the same material should also be used. The flow rate is 0.45 mL per minute, the column temperature is maintained at 50, and the injection volume is 10 μL. The chromatograph is programmed as follows.
Time
(minutes) Solution A (%) Solution B (%) Elution
0–20 97®65 3®35 Linear gradient
20–50 65®0 35®100 Linear gradient
50–60 0 100 Isocratic
60–61 0®97 100®3 Linear gradient for re-equilibration
61–79 97 3 Isocratic for re-equilibration

Chromatograph the reduced Test Solution 3 and the reduced Standard Solution 3, and record the peak responses as directed for Procedure.
Depolymerization Suitability Test— The ratio of the peak area of 1,6-anhydro-DIS-IS to that of 1,6-anhydro DIS is not more than 1.15 for the depolymerized Standard Solution 2.
Column Performance Suitability Test— Identify the peaks corresponding to reduced DIA and 1,6-anhydro-DIS for the Standard Solution 3: the retention time of reduced DIS is between 27 and 33 minutes for the depolymerized and reduced Standard Solution 3; and the resolution, R, between reduced DIA and 1,6-anhydro-DIS is not less than 1.5.
Reduction Suitability Test— The ratio of the peak area of DIS disaccharide to that of reduced DIS in the depolymerized and reduced Standard Solution 3 and Test Solution 3 is not more than 0.02%.
Procedure/Calculation— Separately inject equal volumes of the reduced Test Solutions 3 and the reduced Standard Solution 3 into the chromatograph. Use the normalized area percentage method for calculation. Each peak is integrated from the dwell volume peak to the last detected peak. Measure the area of each analyte peak after excluding solvent peaks at the beginning of the chromatogram and in the Blank Solution. Using the previously obtained chromatograms of the Reduced Disaccharide Solutions, identify peaks belonging to the eight reduced disaccharides in the chromatograms for Test Solution 3 and Standard Solution 3. The peaks belonging to 1,6-Anhydro DIS, 1,6-Anhydro DIIS, and 1,6-Anhydro DIS-ISepi are identified from the relative retention times provided in Table 1 and the Reference chromatogram provided with USP Enoxaparin Sodium RS. Once the peaks have been identified, use the values in Table 1 to calculate the (w/w) percentage of the three main 1,6-anhydro derivatives obtained after depolymerization of enoxaparin sodium using the following formula:
% 1,6-anhydro i (w/w) = (100 × MWi × Ai )/ S(MWx × Ax )
in which MWi and Ai are the molecular weight and the area of the 1,6-anhydro peak i, respectively; and MWx and Ax are the molecular weight and the area, respectively, of either the peak X or the zone X specified by its retention time. [Note— Once the method is established, the peaks belonging to the different di- and tetrasaccharides can be easily identified using the USP Enoxaparin Sodium RS chromatogram. Thus, the use of the disaccharide Standards is only needed during the method-implementation stage. ]
Calculate the molar percentage of components containing a 1,6-anhydro structure at the reducing end of their chain in the enoxaparin sodium test sample according to the following formula:

in which MW is the mass-average molecular mass (see Identification test D under Enoxaparin Sodium ); MWx and Area x are the molecular weight and the area, respectively, of either the peak X or the range X specified by its retention time. The molar percentage of components having a 1,6-anhydro structure at the reducing end of their chain is between 15% and 25%. Typical retention times and molecular masses attributed to different oligosaccharide structures are provided in Table 1 .
Table 1. Typical Relative Retention Times (tRR ) and Molecular Masses Attributed to Different Compounds*
Compound tRR  Molecular Mass (Daltons)
—  < 0.25 741
Reduced DIVA 0.25 401
—  0.25 Reduced DIVS 0.51 461
—  0.51 < tRR < 0.55 483
Reduced DIIA 0.55 503
—  0.55 < tRR < 0.59 503
1,6-Anhydro DIIS 0.59  443
—  0.59 < tRR < 0.64 503
Reduced DIIIA 0.64 503
—  0.64 < tRR < 0.72 533
Reduced DIIS 0.72 563
—  0.72 < tRR < 0.80 563
Reduced DIIIS 0.80 563
—  0.80 < tRR < 0.88 583
Reduced DIA 0.88 605
—  0.88 < tRR < 0.90 635
1,6-Anhydro DIS 0.90  545
—  0.90 < tRR <0.98 635
Reduced DIIA-IVSglu  0.98 1066
—  0.98< tRR <1.00 635
Reduced DIS 1.00 665
—  1.00< tRR <1.04 665
DIS 1.04 665
—  1.04< tRR <1.10 1228
Reduced DIIA-IISglu  1.10 1168
—  1.10< tRR <1.27 1228
1,6-Anhydro DIS-IS  1.27 1210
—  tRR >1.27 1228
* Relative retention times were obtained with a depolymerized and reduced batch of enoxaparin sodium. They are expressed relative to the retention time of the main peak corresponding to reduced DIS. Note that according to the quality of the column, relative retention times can change slightly.

APPENDIX 1: STANDARD DISACCHARIDE STRUCTURES
DIVA DUA-(1®4)-GlcNAc
DIVS DUA-(1®4)-GlcN(NS)
DIIA DUA-(1®4)-GlcNAc(6S)
DIIIA DUA-2S-(1®4)-GlcNAc
DIIS DUA-(1®4)-GlcN (NS,6S)
DIIIS DUA-2S-(1®4)-GlcN (NS)
DIA DUA-2S-(1®4)-GlcNAc(6S)
DIS UA-2S-(1®4)-GlcN (NS,6S)

APPENDIX 2: OLIGOSACCHARIDE STRUCTURES
1,6-Anhydro DIS or
1,6-Anhydro DIS glucose
1,6-Anhydro DIIS or
1,6-Anhydro DIIS glucose
1,6-Anhydro DIIS epi or
1,6-Anhydro DIIS mannose
DIIA-IVSglu
DIIA-IISglu
1,6-Anhydro DIS-IS epi or
1,6-Anhydro DIS-IS mannose

--------------------------------------------------------------------------------

1  Suitable disaccharides are available from Grampian Enzymes (GE-H1001, GE-G1002, GE-H1003, GE-H1004, GE-H1005, GE-H1006, GE-H1007, GE-H1008), Nisthouse, Harray, Orkney, KW17 2LQ, United Kingdom, Tel: 01856 771771, Scottish Local Authority: Orkney Islands.
Auxiliary Information— Please check for your question in the FAQs before contacting USP.
Topic/Question Contact Expert Committee
General Chapter Anita Y. Szajek, Ph.D.
Principal Scientific Liaison
1-301-816-8325 (BIO12010) Monographs - Biologics and Biotechnology 1

USP35–NF30 Page 136
Pharmacopeial Forum: Volume No. 34(1) Page 143